Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high‐dose methylprednisolone, revisited-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chronic lymphocytic leukaemia/small lymphocytic lymphoma treatment with rituximab and high‐dose methylprednisolone, revisited

Published:2021-11-16 Issue:24 Volume:10 Page:8768-8776
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Vagos Mata Ana¹^ORCID,Espada Eduardo¹²,Alves Daniela¹,Polo Blanca¹,Costa Maria João¹,Lopes Conceição¹,F. Lacerda João¹²³,Raposo João¹

Affiliation:

1. Hematology and Bone Marrow Transplant Department Hospital de Santa MariaCentro Hospitalar Universitário Lisboa Norte Lisbon Portugal

2. Instituto de Medicina Molecular João Lobo Antunes Faculdade de Medicina Universidade de Lisboa Lisbon Portugal

3. Faculdade de Medicina Universidade de Lisboa Lisbon Portugal

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4374

Reference22 articles.

1. Actualización de las guías nacionales de consenso del Grupo Español de Leucemia Linfocítica Crónica para el tratamiento y seguimiento de la leucemia linfocítica crónica

2. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

3. Chronic lymphocytic leukemia and autoimmunity: a systematic review

4. Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects

5. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of hub modules and therapeutic targets associated with CD8+T-cells in HF and their pan-cancer analysis;Scientific Reports;2024-08-13

2. Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies;Discover Oncology;2024-07-26

3. Exploring the link between heart failure and cancer: insights into immune mechanisms and therapeutic targets for CD8 + T-cells;2024-03-14

4. Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology;Molecules;2022-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3